DeutschSIMastropaoloJRosseRB.Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin Neuropharmacol. 1998;21:320-332.
6.
NicholasJMLipshitzJSchreiberEC.Phencyclidine: its transfer across the placenta as well as into breast milk. Am J Obstet Gynecol. 1982;143:143-146.
7.
RahbarFFomufodAWhiteDWestneyLS.Impact of intrauterine exposure to phencyclidine (PCP) and cocaine on neonates. J Natl Med Assoc. 1993;85:349-352.
8.
ChasnoffIJBurnsWJHatcherRPBurnsKA.Phencyclidine: effects on the fetus and neonate. Dev Pharmacol Ther. 1983;6:404-408.
9.
AhmadG.Abuse of phencyclidine (PCP) a laboratory experience. J Toxicol Clin Toxicol. 1987;25:341-346.
10.
GoldenNLSokolRJRubinIL.Angel dust: possible effects on the fetus. Pediatrics. 1980;65:18-20.
11.
TaborBLSmith-WallaceTYonekuraML.Perinatal outcome associated with PCP versus cocaine use. Am J Drug Alcohol Abuse. 1990;16:337-348. doi:10.3109/00952999009001595
12.
GoldenNLKuhnertBRSokolRJMartierSWilliamsT.Neonatal manifestations of maternal phencyclidine exposure. Journal of Perinatal Medicine. 1987;15(2):185-192. doi:10.1515/jpme.1987.15.2.185
13.
WachsmanLSchuetzSChanLSWingertWA.What happens to babies exposed to phencyclidine (PCP) in utero?Am J Drug Alcohol Abuse. 1989;15:31-39.
14.
MvulaMMMillerJMRaganFA.Relationship of phencyclidine and pregnancy outcome. J Reprod Med. 1999;44(12):1021-1024.